H. Fibiger

Directeur/Membre du Conseil chez ImStar Therapeutics, Inc.

Profil

H.
Christian Fibiger currently works at ImStar Therapeutics, Inc., as Director, AiVita Biomedical, Inc., as Director from 2022, and GABA Therapeutics, Inc., as Director.
Dr. Fibiger also formerly worked at MSI Methylation Sciences, Inc., as Director, iCo Therapeutics, Inc., as Director from 2008 to 2009, biOasis Technologies, Inc., as Independent Director from 2010 to 2017, Sirius Genomics, Inc., as Director, Amgen, Inc., as VP & Global Head-Neuroscience Therapeutic Area in 2007, Eli Lilly & Co., as VP-Neuroscience Discovery Research, the University of British Columbia, as Head-Neurological Sciences Division, Biovail Laboratories International SRL, as Chief Scientific Officer & Senior Vice President from 2008 to 2010, HLS Therapeutics, Inc., as Chief Scientific Officer, and MedGenesis Therapeutix, Inc., as Chief Scientific Officer from 2010 to 2017.
Dr. Fibiger received his doctorate degree in 1970 from Princeton University and undergraduate degree in 1966 from the University of Victoria.

Postes actifs de H. Fibiger

Sociétés	Poste	Début
ImStar Therapeutics, Inc.	Directeur/Membre du Conseil	-
GABA Therapeutics, Inc.	Directeur/Membre du Conseil	-
AiVita Biomedical, Inc.	Directeur/Membre du Conseil	05/04/2022

Anciens postes connus de H. Fibiger

Sociétés	Poste	Fin
BIOASIS TECHNOLOGIES INC.	Directeur/Membre du Conseil	21/09/2017
MedGenesis Therapeutix, Inc.	Directeur Technique/Scientifique/R&D	01/01/2017
Biovail Laboratories International SRL	Directeur Technique/Scientifique/R&D	01/01/2010
SATELLOS BIOSCIENCE INC.	Directeur/Membre du Conseil	05/06/2009
AMGEN INC.	Corporate Officer/Principal	01/01/2007